Financial Times M&A

DECEMBER 15, 2024

49

49

Appraisers Blog

DECEMBER 15, 2024

40

40

Benzinga

DECEMBER 15, 2024

Proposed acquisition strengthens Pharming's late-stage pipeline with a potential first-in-disease asset Abliva's lead product KL1333 is currently in a pivotal clinical trial, with a positive interim analysis achieved, in mitochondrial DNA-driven primary mitochondrial diseases Total transaction value of approximately US$66.1 million No external funding required to fund acquisition and KL1333 development costs Pharming to host a conference call on Monday, December 16, 2024 at 14:00 CET (

Technology 40

Technology 40

Appraisers Blog

DECEMBER 15, 2024

40

40

Speaker: Susan Spencer, Principal of Spencer Communications

Intent signal data can go a long way toward shortening sales cycles and closing more deals. The challenge is deciding which is the best type of intent data to help your company meet its sales and marketing goals. In this webinar, Susan Spencer, fractional CMO and principal of Spencer Communications, will unpack the differences between contact-level and company-level intent signals.

Marketability

Equilest

DECEMBER 15, 2024

Want to understand the intricacies of service business valuation? Dive into our detailed breakdown to learn how to assess and maximize your companys value! Valuation of Service Business If you own or manage a service-based business, knowing the value of your company is super important! Whether you're thinking about selling, looking for financing, or just want to understand the health of your business, a thorough valuation can offer amazing insights.

Intangible Assets 40

Intangible Assets Business Valuation Discounted Cash Flow Marketability 40

Harvard Corporate Governance

DECEMBER 15, 2024

Posted by Martha Carter, Matt Filosa, andFaten Alqaseer, Teneo, on Sunday, December 15, 2024 Editor's Note: Martha Carter is Vice Chair and Head of Governance Advisory, and Matt Filosa and Faten Alqaseer are Senior Managing Directors, at Teneo. This post is based on a Teneo memorandum by Ms. Carter, Mr. Filosa, Ms. Alqaseer, Kensey Biggs , Diana Lee , and Rose James.

113

113

Benzinga

DECEMBER 15, 2024

Westford, USA, Dec. 15, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the global stem cell banking market share will reach a value of USD 18.65 Billion by 2031 , with a CAGR of 18.30% during the forecast period (2024-2031). As cryopreservation and cell bank preparation techniques are getting advanced, the stem cell banking market is expanding rapidly.

Banking 40

Banking Marketability Technology 40

Reynolds Holding

DECEMBER 15, 2024

We today announce the formation of The Shadow SEC, an independent organization of six current academics that, like the earlier established Federal Reserve Shadow Open Market Committee, is intended to provide, encourage, facilitate, and distribute policy discussions and debates relating to the federal securities laws and the Securities and Exchange Commission (SEC).

Finance 49

Finance Corporate Finance Marketability Compliance 49

Benzinga

DECEMBER 15, 2024

Westford, USA, Dec. 15, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the global healthcare analytical testing services market size will reach a value of USD 15.55 Billion by 2031 , with a CAGR of 11.2% during the forecast period (2024-2031). The market's main driving factors are the number of companies in the pharmaceutical and medical device industries that outsource analytical testing services, increased clinical trials in need of analytical testing, and the rising emphasis on biosimil

Marketability 40

Marketability Technology 40